Veterinary Rapid Test Market Size

Veterinary Rapid Test Market size was valued at USD 925.68 million in 2024 and is expected to exceed USD 4.08 billion by the end of 2037, registering over 12.1% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of veterinary rapid test is evaluated at USD 1.01 billion.

The natural ability of animals to transmit diseases to humans increases the threat to public health from zoonotic diseases. Zoonotic diseases fall into one of three categories:  endemic, endemic, and emerging and re-emerging. Zoonoses are estimated to account for up to 75% of newly discovered or emerging infectious diseases and approximately 60% of recorded infectious diseases. Worldwide, over 2.5 billion human illnesses and over 2.7 million deaths each year are thought to be caused by zoonotic diseases. Additionally, zoonotic diseases are prevalent worldwide and in the United States.

The use of state-of-the-art technologies such as real-time polymerase chain reaction, next-generation sequencing, and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry has significantly advanced the clinical laboratory diagnosis of animal diseases over the past few years. However, all these methods require highly qualified personnel, special equipment, and laboratory space. As a result, there is a growing demand for point-of-care testing for disease diagnosis and animal health. Currently, available assays include a wide range of assays based on antibodies, antigens, nucleic acids, and nanopore sequencing. Every test consists of their individual weakness and strength.